Trial · NCT03442322
Registered outcomes24
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 24
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Dispensing of Psychotropic Medications | 6-month period (months 1-6) | Percentage of nursing home residents with dementia who received one or more antipsychotic medication over Months 1-6 of Intervention. |
| Primary | Dispensing of Psychotropic Medications | 12-month period (months 7-12) | Percentage of nursing home residents with dementia who received one or more antipsychotic medication over Months 7-12 of Intervention. |
| Primary | Dispensing of Psychotropic Medications | 18-month period (months 13-18) | Percentage of nursing home residents with dementia who received one or more antipsychotic medication over Months 13-18 of Intervention. |
| Primary | Behavioral Symptoms | 6-month period (months 1-6) | Percentage of nursing home residents with dementia who had behavioral symptoms over Months 1-6 of Intervention. |
| Primary | Behavioral Symptoms | 12-month period (months 7-12) | Percentage of nursing home residents with dementia who had behavioral symptoms over Months 7-12 of Intervention. |
| Primary | Behavioral Symptoms | 18-month period (months 13-18) | Percentage of nursing home residents with dementia who had behavioral symptoms over Months 13-18 of Intervention. |
| Primary | Wandering | 6-month period (months 1-6) | Percentage of nursing home residents with dementia who had wandering over Months 1-6 of Intervention. |
| Primary | Wandering | 12-month period (months 7-12) | Percentage of nursing home residents with dementia who had wandering over Months 7-12 of Intervention. |
| Primary | Wandering | 18-month period (months 13-18) | Percentage of nursing home residents with dementia who had wandering over Months 13-18 of Intervention. |
| Primary | Rejection of Care | 6-month period (months 1-6) | Percentage of nursing home residents with dementia who had rejection of care over Months 1-6 of Intervention. |
| Primary | Rejection of Care | 12-month period (months 7-12) | Percentage of nursing home residents with dementia who had rejection of care over Months 7-12 of Intervention. |
| Primary | Rejection of Care | 18-month period (months 13-18) | Percentage of nursing home residents with dementia who had rejection of care over Months 13-18 of Intervention. |
| Secondary | Unintended Weight Loss | 6-month period (months 1-6) | Percentage of nursing home residents with dementia who had unintended weight loss over Months 1-6 of Intervention. |
| Secondary | Unintended Weight Loss | 12-month period (months 7-12) | Percentage of nursing home residents with dementia who had unintended weight loss over Months 7-12 of Intervention. |
| Secondary | Unintended Weight Loss | 18-month period (months 13-18) | Percentage of nursing home residents with dementia who had unintended weight loss over Months 13-18 of Intervention. |
| Secondary | Falls | 6-month period (months 1-6) | Percent of nursing home residents with dementia who had falls over Months 1-6 of Intervention. |
| Secondary | Falls | 12-month period (months 7-12) | Percent of nursing home residents with dementia who had falls over Months 7-12 of Intervention. |
| Secondary | Falls | 18-month period (months 13-18) | Percent of nursing home residents with dementia who had falls over Months 13-18 of Intervention. |
| Secondary | Depressive Symptoms | 6-month period (months 1-6) | Percent of nursing home residents with dementia who had depressive symptoms over Months 1-6 of Intervention |
| Secondary | Depressive Symptoms | 12-month period (months 7-12) | Percent of nursing home residents with dementia who had depressive symptoms over Months 7-12 of Intervention. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03442322/registered